United States (federal)

US Clinical Laboratory Improvement Amendments (CLIA) Regulations (42 CFR Part 493)

52 controls. 1 other frameworks in our corpus share controls with it. Here is all of it, and how much of it you are already doing.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

52 controls 1 frameworks share controls with it United States (federal) verified against its source document

Every control below is one this framework asks for. The right hand column counts how many other frameworks in our corpus carry the same control, which is the difference between doing this work once and doing it again for the next standard.

There is no implementation kit for this framework yet. The control list and the overlap above are free and complete.

What you already have

Frameworks whose controls overlap this one, most first. If you run any of them, the count is roughly what you have already evidenced.

If you runShared controls
ISO 15189:202239measure it →

Every control

CodeControlAlso in
1-25Basis, scope, definitions, applicability and the three complexity categories: every facility testing human specimens for health assessment or diagnosis must hold a CLIA certificate0
1101Keep the laboratory constructed, arranged and maintained with adequate space, ventilation and utilities, contamination minimised, uni-directional workflow for open molecular amplif1
1103Where transfusion services are provided, hold an approved transfusion service agreement, provide prompt ABO grouping, D typing, antibody detection, compatibility testing and transf0
1105Retain records for the CLIA minimum periods: requisitions, procedures, analytic and quality control records, PT records, quality assessment records and test reports for two years, 1
1200Establish and maintain written policies and procedures implementing and monitoring a quality system across the general laboratory, preanalytic, analytic and postanalytic phases, wi1
1231Ensure confidentiality of patient information throughout every phase of the total testing process under the laboratory's control1
1232Establish and follow written policies and procedures that ensure positive identification and optimum integrity of each patient specimen from collection or receipt through testing a1
1233Operate a system that documents every complaint and problem reported to the laboratory and investigates complaints where appropriate1
1234Identify and document problems arising from breakdowns in communication between the laboratory and the authorised persons who order or receive test results1
1235Establish and follow written policies and procedures to assess the competency of employees and, where applicable, consultants, as the Subpart M personnel responsibilities require1
1236Review and evaluate all proficiency testing results, verify the accuracy of any unscored or unevaluated analyte, and at least twice a year verify the accuracy of every test not cov1
1239Run an ongoing, documented general laboratory systems quality assessment that monitors, assesses and corrects problems in confidentiality, specimen identification, complaints, comm1
1241Accept testing only on a written or electronic request from an authorised person (or an oral request followed within 30 days by written authorisation), ensure the requisition solic1
1242Establish and follow written procedures for patient preparation, specimen collection, labelling, storage and preservation, transport, processing, acceptability and rejection, and r1
1249Run an ongoing, documented preanalytic systems quality assessment covering test requests and specimen submission, handling and referral, with effectiveness review of corrective act1
1251Maintain a written procedure manual for every test, assay and examination, followed by staff, containing the fourteen required elements where applicable, approved, signed and dated1
1252Select test systems and perform testing to the manufacturer's instructions within the laboratory's stated performance specifications; define, monitor and document the storage and o1
1253Before reporting patient results on an unmodified FDA-cleared or approved test system, verify accuracy, precision and reportable range and confirm the manufacturer's reference inte1
1254Perform and document maintenance and function checks for unmodified manufacturer systems as the manufacturer defines and at least as often as specified, with function checks within1
1255Calibrate each test system per the manufacturer's instructions and the laboratory's established criteria, with traceable materials where possible; verify calibration across the rep1
1256Operate control procedures for every test system that detect immediate errors and monitor accuracy and precision over time: at least daily two levels for quantitative tests, positi1
1261-1265Meet the microbiology specialty control requirements: reactivity checks of beta-lactamase, Gram stain, antisera and mycobacterial reagents at the stated frequencies; control organi1
1267-1269Meet the routine chemistry and hematology specialty control requirements: blood gas calibration or verification per the manufacturer, a low and high control each eight hours of tes1
1271Meet the immunohematology requirements: perform ABO, D typing, antibody detection and identification and compatibility testing per the manufacturer and 21 CFR 606.151; confirm ABO 0
1273Meet the histopathology requirements: control slides of known reactivity with each special stain and fluorescent and immunohistochemical stain checks each time of use, documented; 1
1274Meet the cytology requirements: evaluate all slides on the premises of a cytology-certified laboratory; Papanicolaou staining and cross-contamination controls; a documented error-d1
1276-1278Meet the clinical cytogenetics and histocompatibility requirements: specimen identification through accessioning, culture, imaging and reporting, records of media, cells counted an0
1281Twice a year evaluate and define the relationship between results for the same test performed by different methods, instruments or sites, and maintain a system that flags patient r1
1282Maintain and follow corrective action procedures, and document every corrective action taken when test systems fall outside established performance specifications, when calibration1
1283Maintain a test record system that captures positive specimen identification, the date and time of receipt, the condition and disposition of unacceptable specimens, and the records1
1289Run an ongoing, documented analytic systems quality assessment covering the procedure manual, test systems, performance specifications, maintenance, calibration, controls, specialt1
1291Report results through a system that transmits them accurately and timely from data entry to final destination; include patient identification, performing laboratory name and addre1
1299Run an ongoing, documented postanalytic systems quality assessment of test reporting, with effectiveness review of corrective actions, procedure revision to prevent recurrence and 1
1355-1365For provider-performed microscopy procedures, have a qualified director (physician, independently practising midlevel practitioner or dentist, State-licensed where required) who di1
1405-1489Employ only personnel who meet the Subpart M qualification standards for their role and the complexity of testing: laboratory director, technical consultant, clinical consultant an1
1407-1445The laboratory director takes responsibility for overall operation and administration and for compliance, is onsite at least twice a year at least four months apart with documented1
1413-1451The technical consultant (moderate complexity) or technical supervisor (high complexity, by specialty) provides accessible technical and scientific oversight: method selection, ver1
1419-1457The clinical consultant is available to advise the laboratory's clients on the appropriateness of tests ordered and the interpretation of results, and ensures reports carry the inf1
1425-1495Testing personnel (and cytotechnologists) perform only the tests the director authorises and that match their skill; follow the laboratory's procedures for handling, testing, repor1
1463-1471For high complexity testing the general supervisor is accessible to testing personnel whenever testing is performed, provides day-to-day supervision, is onsite to directly supervis1
1773Permit CMS or its agent to inspect, revisit and investigate complaints: allow testing of samples including PT samples, interviews of all personnel, observation of every phase of te0
1775-1780Accept the inspection regime for the certificate held: waived and PPM laboratories are inspected at any time to check for imminent risk, complaints, testing beyond the certificate 0
1800-1850Enforcement procedures: principal and alternative sanctions, immediate jeopardy, condition-level and standard-level deficiencies, directed plans of correction, civil money penaltie0
2001The Clinical Laboratory Improvement Advisory Committee: HHS's standing advisory body on the criteria for test categorisation, standards and the use of new technology0
35-63Hold the CLIA certificate that matches the complexity of testing performed, apply and renew on the HHS form, and notify CMS within 30 days of any change of ownership, name, locatio0
551-567Deemed status through an approved accreditation organisation: obtain the certificate of accreditation, pay the fees, meet the proficiency testing subpart, authorise the PT program 0
553-680Approval and oversight of accreditation organisations and State licensure programs, publication of deeming authority, and the certificate fee schedule0
801(a)Enrol in a CMS-approved proficiency testing program for every specialty, subspecialty and regulated analyte the laboratory is certified to perform, designate the program used for e1
801(b)Test proficiency testing samples exactly as patient specimens, within the routine workload by the staff who normally test, the same number of times, with no inter-laboratory commun1
803-807Participate successfully in proficiency testing for each specialty, subspecialty and analyte certified, take remedial action when an individual fails gynecologic cytology, and, aft1
821-865Meet the specialty and subspecialty proficiency testing criteria: for each microbiology, immunology, chemistry, hematology, gynecologic cytology and immunohematology event, the lab0
901-959Approval and administration of proficiency testing programs (Subpart I): the criteria HHS applies to programs, the number of challenges and the analytes regulated per specialty0

Tell me when US Clinical Laboratory Improvement Amendments (CLIA) Regulations (42 CFR Part 493) files something new

One email when a public company newly discloses something this framework governs, naming the company and what our corpus says it puts in scope. Nothing else, and one click to stop.

What this page is

A control-level reference for US Clinical Laboratory Improvement Amendments (CLIA) Regulations (42 CFR Part 493), drawn from our framework corpus. Control codes and titles are references to the standard, not reproductions of it. The overlap counts and the auditor artefacts are our own work and are the part you will not find elsewhere.

Measure this against what you already run · All frameworks · Today's edition